Wang, L., Chan, C., Wong, A., Wong, F., Lim, S., Chinnathambi, A., . . . Goh, B. (2017). Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1. Impact Journals LLC.
Chicago Style (17th ed.) CitationWang, L., et al. Combined Use of Irinotecan with Histone Deacetylase Inhibitor Belinostat Could Cause Severe Toxicity by Inhibiting SN-38 Glucuronidation via UGT1A1. Impact Journals LLC, 2017.
MLA (9th ed.) CitationWang, L., et al. Combined Use of Irinotecan with Histone Deacetylase Inhibitor Belinostat Could Cause Severe Toxicity by Inhibiting SN-38 Glucuronidation via UGT1A1. Impact Journals LLC, 2017.
Warning: These citations may not always be 100% accurate.